The care of newborns demands meticulous attention, especially considering the delicate nature of their early life stage. In 2020, a concerning 2.4 million children globally succumbed in their first month, accounting for 47% of all child deaths under five years. This alarming statistic underscores the need for enhanced pediatric care and adherence to medical guidelines for newborn care, including vaccinations and other essential medical requirements.
Newborns are particularly susceptible to environmental factors, viruses, and other diseases, posing significant medical concerns. The genetic strength of an embryo, a factor not guaranteed even in natural conception, plays a crucial role in a baby’s survival and growth. In this context, In Vitro Fertilization (IVF) with Preimplantation Genetic Screening/Testing (PGS/PGT) emerges as a powerful solution. This advanced reproductive technology facilitates the selection of genetically robust embryos, significantly reducing the risk of mortality and ensuring the birth of a healthy baby.
The aftermath of COVID-19 and ongoing climate change have introduced new challenges for prospective parents, potentially impacting their future children. It is imperative for governments to conduct thorough case studies to understand these impacts and safeguard future generations from the consequences of COVID-19. The increased mortality among young individuals due to post-COVID complications raises concerns about the potential transference of these impacts from parents to their offspring. Selecting the best genetic makeup through advanced reproductive technologies could be a precautionary measure to combat future health challenges, including those posed by viruses like COVID-19.
The need for comprehensive newborn care is more critical than ever in the face of modern health challenges. By integrating advanced reproductive technologies like IVF with PGS/PGT and enhancing pediatric care, we can significantly improve the survival rates and health of newborns. Governments, healthcare providers, and communities must work collaboratively to implement effective strategies and ensure the well-being of the youngest members of our society.
IVF cost in Mumbai is ₹1.2L to ₹2.5L. We offer high success rates with guaranteed IVF programs customized based on your needs.
Read More about IVF cost in MumbaiSurrogacy cost in India is around INR 15 lakhs to INR 20 lakhs. India offers a guaranteed surrogacy program with additional IVF cycles and multiple embryo transfers..
Read More about surrogacy cost in IndiaSurrogacy with medical, legal, and postpartum care in Delhi costs between ₹18 lakh to ₹20 lakh. Enforcing the law that comes in 2023, which grants the privilege of altruistic surrogacy under stern guidelines exclusively, is given to the National Surrogacy Board.
Learn more about surrogacy costs Delhi